The term SH3 and PX domains 2A inhibitors refers to a specific category of chemical compounds that have the ability to modulate the activity of the SH3 (Src Homology 3) and PX (Phox Homology) domains within cellular proteins. These domains play crucial roles in intracellular signaling and membrane trafficking processes. SH3 domains are protein modules involved in protein-protein interactions, while PX domains are lipid-binding domains that facilitate the recruitment of proteins to cell membranes. Inhibitors targeting SH3 and PX domains 2A are designed to interfere with the normal functioning of proteins that contain these domains. By binding to these domains or altering their conformation, these inhibitors can disrupt the interactions between proteins, thereby influencing various cellular processes. Understanding the mechanisms by which these inhibitors affect SH3 and PX domains 2A can provide valuable insights into the regulation of intracellular signaling, membrane dynamics, and cellular trafficking pathways, contributing to our knowledge of fundamental cellular biology.
Researchers study these inhibitors to elucidate the intricate molecular mechanisms underlying cellular processes and to explore their roles in various physiological and pathological conditions. By investigating the interactions between these inhibitors and SH3 and PX domains 2A, scientists aim to gain a deeper understanding of how cells regulate essential functions such as cell signaling and membrane transport. This knowledge can have broader implications for fields like cell biology and biochemistry, offering insights into the development of new tools and strategies for manipulating cellular processes for research purposes.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis in eukaryotic organisms. By halting protein production, it may indirectly reduce SH3PXD2A levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a well-known inhibitor of the mTOR pathway, which is involved in protein synthesis and cell growth. Inhibiting mTOR could reduce SH3PXD2A expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA synthesis. By preventing mRNA production, it could indirectly decrease SH3PXD2A protein levels. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein transportation in cells, potentially leading to reduced SH3PXD2A function or stability. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to inhibit lysosomal function and autophagy, which could potentially influence SH3PXD2A degradation or function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 inhibits the proteasome, potentially leading to altered protein degradation and influencing SH3PXD2A levels. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
As a glycolysis inhibitor, 2-Deoxy-D-glucose might indirectly influence cellular energy balance and SH3PXD2A expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. Inhibiting JNK signaling could have indirect effects on SH3PXD2A, as JNK is involved in various cellular processes. | ||||||
SB 202190 | 152121-30-7 | sc-202334 sc-202334A sc-202334B | 1 mg 5 mg 25 mg | $31.00 $128.00 $454.00 | 45 | |
SB203580 is a p38 MAPK inhibitor, and since SH3PXD2A is implicated in MAPK signaling, this compound might indirectly influence its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, a kinase in the MAPK pathway. Inhibiting MEK could indirectly affect SH3PXD2A. | ||||||